Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Treatment Resistant Depression
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 25 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04670081
- Collaborators
- Charite University, Berlin, Germany
- MIND Foundation gGmbH
- German Federal Ministry of Education and Research
- Usona Institute
- Investigators
- Principal Investigator: Gerhard Gründer, Prof. Dr. Central Institute of Mental Health, Mannheim